Tuesday | The Motley Fool
That's a pitch I'm sure you've heard some semblance of at cocktail parties, golf outings, weddings, and, of course, on the Internet.
Crocs, Taser: Early Volume Movers
Several small-cap stocks were poised to move on above-average volume during Friday's session Novavax slipped by 3 cents, or 0.7%, to $4 after the company reported a third-quarter loss of 8 cents a share, a penny better than the Thomson Reuters average estimate.
While Novavax moves closer to commercializing its flu vaccines, it continues to lose money.
RothmanResearch.com Equity Review for PWE, GNA, RX, TMR, GSS and NVAX
On this day, we have begun tracking the following companies as they have shown remarkable correction in recent days, you can access these free reports with a number of other reviews by signing up for your complimentary membership at: Penn West Energy Trust - Sector: Basic Materials Gerdau AmeriSteel Corp.
Customer Interaction Solutions
Stock-PR.com Announces Daily Stock Watch: NVAX, HGSI, AMGN
Stock-PR.com, a division of Crown Equity Holdings Inc. tracks stocks daily and is pleased to offer its hot stock alerts.
Novavax seasonal flu vaccine meets study goal
Biotechnology company Novavax Inc. said Monday its seasonal flu vaccine candidate met key goals in a midstage clinical trial.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 10/30/09, Covidien , a leading global provider of healthcare products, announced its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration approval of its Abbreviated New Drug Application for Oral Transmucosal Fentanyl ...
CPL Biologicals Building Flu Vaccine Plant
CPL Biologicals Pvt. Ltd., a joint venture between biotechnology company Novavax Inc.
CPL Biologicals to build new flu vaccine plant
CPL Biologicals Pvt. Ltd., a joint venture between biotechnology company Novavax Inc.
Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India
Novavax, Inc. announced today that CPL Biologicals Pvt. Ltd., the new joint venture between Cadila Pharmaceuticals in India, has begun construction of a state-of-the-art manufacturing facility that will be used to produce pandemic and seasonal influenza vaccines.
Dollar Store: Early Volume Plays
Several small-cap stocks were poised to move on above-average volume during Wednesday's session Novavax rose by 7 cents, or 1.8%, to $3.92 in the premarket session after the company said it has entered into a strategic collaboration with Xcellerex to develop a large-scale manufacturing process for its 2009 H1N1 influenza VLP vaccine.
Novavax, partner to test H1N1 vaccine
Novavax Inc. is partnering with a Mexican vaccine maker to run the Rockville biotech's largest clinical trials to date to test its vaccine technology against the pandemic H1N1 flu strain.
Novavax, Xcellerex Partner On Swine Flu Manufacturing
Novavax Inc. said Wednesday it will work with Xcellerex Inc. to increase production of a potential swine flu vaccine.
Swine Flu Shot Gets Mexican Test
A vaccine for the 2009 H1N1 influenza virus made in insect cells could be approved in Mexico as early as next year.
Novavax, GE, Avimex Set Mexico H1N1 Vaccine Trial
Novavax Inc., the Rockville, Md., biotech company, said on Tuesday that it began a two-stage clinical study in Mexico of a vaccine for H1N1 influenza.
MedImmune, Novavax debate vaccines
Two Maryland biotechnology firms began working feverishly in April to formulate swine flu vaccines - one through classic methods that produced a usable vaccine and the other with newer technology that could speed production in the face of a pandemic.
Weekly Digest's Investor Essentials Special Report Identifies Unique...
Weekly Digest , a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for Alpha Pro Tech , Novavax , Generex Biotechnology , Inovio Biomedical , AstraZeneca and several others.
Ivanhoe Energy (IVAN) - Top Gainers on NASDAQ
Dallas, TX - Sequenom, Inc. jumped up by 10.78% to close at $3.70 on a massive volume of 16.41 million shares after Sequenom yesterday announced that all its data is bogus.
Also on Topix